Collaborate Disseminate
New Australian research is systematically investigating the anticonvulsant effects of a number of rare compounds in cannabis. A new study is reporting cannabigerolic acid (CBGA), informally known as the “mother of all cannabinoids,” may be more effecti… Continue reading CBGA, the “mother of all cannabinoids”, reduces seizures more effectively than CBD
With the Tokyo Olympics almost upon us, the world’s best athletes are converging on Japan and it seems inevitable the topic of performance-enhancing drugs will at some point rear its head. The usual suspects – steroids, stimulants, etc. – will obviousl… Continue reading Performance-enhancing psychedelics: Can LSD make you better at sport?
A recently published study in the journal Scientific Reports is presenting evidence to suggest molecules called terpenes synergistically interact with cannabinoids to contribute to the therapeutic effects of cannabis. The research supports a controvers… Continue reading The entourage effect: Is cannabis more than just THC and CBD?
A recently published study in the journal Scientific Reports is presenting evidence to suggest molecules called terpenes synergistically interact with cannabinoids to contribute to the therapeutic effects of cannabis. The research supports a controvers… Continue reading The entourage effect: Is cannabis more than just THC and CBD?
An extraordinary new study from a team of scientists at Yale University is reporting the first direct cellular demonstration of a single psilocybin dose inducing neural plasticity in a mammalian brain. The researchers show how the psychedelic prompts r… Continue reading Landmark study shows one dose of psilocybin induces new neural connections
For around half a century the randomized controlled trial (RCT) has been considered the gold standard in evaluating the effectiveness of any new medical intervention. The process involves recruiting a group of participants with a certain condition and … Continue reading The problem at the heart of modern psychedelic clinical research
A Phase 2 clinical trial has found a 60-minute treatment session with the gas nitrous oxide can deliver significant and rapid improvements in patients with treatment-resistant depression, and the research indicates these benefits can last for at least … Continue reading Nitrous oxide, or “laughing gas”, rapidly relieves severe depression
With psychedelic-assisted psychotherapy on the cusp of broad clinical approval in the United States, there is a new pressing need to understand exactly which patients may be best suited to this novel treatment and which patients are most at risk of adv… Continue reading Can a genetic test predict your response to psychedelic drugs?
The first results from Phase 3 trials testing MDMA-assisted psychotherapy for post-traumatic stress disorder (PTSD) have been announced. The extremely promising data are the first Phase 3 results to be revealed for any psychedelic-based therapy, paving… Continue reading First Phase 3 trial data for MDMA therapy sets path for approval
A new study from researchers at Syracuse University is presenting results from one of the first placebo-controlled trials exploring the influence of CBD on sensations of acute pain. The mixed results suggest CBD may reduce feelings of unpleasantness, h… Continue reading “Surprising” results from new CBD pain study